Literature DB >> 12647209

Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance.

Rodolfo Montironi1, Roberta Mazzucchelli, Theodorus Kwast.   

Abstract

The increase in prostate cancer detection has induced a sharp increase in the number of radical prostatectomies Proper examination of radical prostatectomy (RP) specimens by pathologists is critical in determining the need for adjuvant treatment and prediction of patient outcome. The pathology report should include relevant clinical information as well as provide prognostically useful information derived from the macroscopic examination and microscopic evaluation of the RP specimen

Entities:  

Mesh:

Year:  2003        PMID: 12647209     DOI: 10.1007/s00428-002-0741-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer Committee.

Authors:  J R Srigley; M B Amin; D G Bostwick; D J Grignon; M E Hammond
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

Review 2.  Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

Authors:  D G Bostwick; D J Grignon; M E Hammond; M B Amin; M Cohen; D Crawford; M Gospadarowicz; R S Kaplan; D S Miller; R Montironi; T F Pajak; A Pollack; J R Srigley; J W Yarbro
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

Review 3.  Evaluation of prognostic factors in radical prostatectomy specimens with cancer.

Authors:  Roberta Mazzucchelli; Alfredo Santinelli; Antonio Lopez-Beltran; Marina Scarpelli; Rodolfo Montironi
Journal:  Urol Int       Date:  2002       Impact factor: 2.089

4.  Androgen-deprived prostate adenocarcinoma: evaluation of treatment-related changes versus no distinctive treatment effect with a Bayesian belief network. A methodological approach.

Authors:  R Montironi; P H Bartels; D Thompson; L Diamanti; E Prete
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

5.  Staging and reporting of prostate cancer--sampling of the radical prostatectomy specimen.

Authors:  W A Sakr; T M Wheeler; M Blute; M Bodo; R Calle-Rodrigue; D E Henson; F K Mostofi; J Seiffert; K Wojno; H Zincke
Journal:  Cancer       Date:  1996-07-15       Impact factor: 6.860

Review 6.  Pathological changes in prostate lesions after androgen manipulation.

Authors:  R Montironi; C C Schulman
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

7.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

Review 8.  Histologic grading of prostate cancer: a perspective.

Authors:  D F Gleason
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

9.  Significance of small foci of Gleason score 7 or greater prostate cancer on needle biopsy.

Authors:  X J Yang; K Lecksell; S R Potter; J I Epstein
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

Review 10.  Staging prostate cancer.

Authors:  R F Hoedemaeker; A N Vis; T H Van Der Kwast
Journal:  Microsc Res Tech       Date:  2000-12-01       Impact factor: 2.769

View more
  10 in total

Review 1.  Current practice of Gleason grading of prostate carcinoma.

Authors:  Antonio Lopez-Beltran; Gregor Mikuz; Rafael J Luque; Roberta Mazzucchelli; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2005-11-23       Impact factor: 4.064

2.  Macrocryosectioning and complete sampling of the prostate in a potential multiorgan donor candidate.

Authors:  Roberta Mazzucchelli; Marina Scarpelli; Antonio Lopez-Beltran; Liang Cheng; Rodolfo Montironi
Journal:  J Clin Pathol       Date:  2007-08       Impact factor: 3.411

Review 3.  Optimum slicing of radical prostatectomy specimens for correlation between histopathology and medical images.

Authors:  Li Hong Chen; Henry Ho; Richie Lazaro; Choon Hua Thng; John Yuen; Wan Sing Ng; Chris Cheng
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-02-24       Impact factor: 2.924

4.  Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer.

Authors:  Roberta Mazzucchelli; Doriana Morichetti; Alfredo Santinelli; Marina Scarpelli; Aldo V Bono; Antonio Lopez-Beltran; Liang Cheng; Rodolfo Montironi
Journal:  Cell Oncol (Dordr)       Date:  2011-04-30       Impact factor: 6.730

5.  Surgical margin status of specimen and oncological outcomes after laparoscopic radical prostatectomy: experience after 400 procedures.

Authors:  Francesco Porpiglia; Cristian Fiori; Matteo Manfredi; Susanna Grande; Massimiliano Poggio; Enrico Bollito; Mauro Papotti; Roberto Mario Scarpa
Journal:  World J Urol       Date:  2011-06-23       Impact factor: 4.226

6.  Interobserver reproducibility of modified Gleason score in radical prostatectomy specimens.

Authors:  Axel Glaessgen; Hans Hamberg; Carl-Gustaf Pihl; Birgitta Sundelin; Bo Nilsson; Lars Egevad
Journal:  Virchows Arch       Date:  2004-05-20       Impact factor: 4.064

7.  A retrospective study on pathologic features and racial disparities in prostate cancer.

Authors:  Steven A Bigler; Charles R Pound; Xinchun Zhou
Journal:  Prostate Cancer       Date:  2011-10-31

8.  Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer.

Authors:  Francesco Porpiglia; Filippo Russo; Matteo Manfredi; Fabrizio Mele; Cristian Fiori; Daniele Regge
Journal:  Int Braz J Urol       Date:  2015 Jan-Feb       Impact factor: 1.541

9.  Quantifying Tumor Heterogeneity from Multiparametric Magnetic Resonance Imaging of Prostate Using Texture Analysis.

Authors:  Saleh T Alanezi; Frank Sullivan; Christoph Kleefeld; John F Greally; Marcin J Kraśny; Peter Woulfe; Declan Sheppard; Niall Colgan
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

10.  Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy.

Authors:  Roberta Mazzucchelli; Francesca Barbisan; Adriano Tagliabracci; Antonio Lopez-Beltran; Liang Cheng; Marina Scarpelli; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2007-02-07       Impact factor: 4.064

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.